Visceral Leishmaniasis
📧 Sign up to get email alerts when something new happens for Visceral Leishmaniasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: LEISH-PED: Study on Leishmaniasis in Children
A pediatric LEISH-PED trial on Leishmaniasis in children is currently recruiting at Meyer Children's Hospital IRCCS, including visceral, cut…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Human Bioequivalence Study of Liposomal Amphotericin B for Injection [NA]
This document reports a human bioequivalence study of liposomal amphotericin B for injection that is currently active but not recruiting, sp…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Recurrent Visceral Leishmaniasis in HIV Co-Infection
Clinical trial NCT07487350 is in recruitment, sponsored by the Institute of Tropical Medicine, Belgium, studying recurrent visceral leishman…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study [Phase 2]
A Phase 2 proof-of-concept trial of LXE408 for primary visceral leishmaniasis in Ethiopia has completed.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis [Phase 2]
Phase II multicentre randomized blinded study to evaluate the efficacy and safety of two LXE408 regimens for primary visceral leishmaniasis;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Human Bioequivalence Study of Amphotericin B Liposome for Injection [NA]
Completed a human bioequivalence study of liposomal amphotericin B for injection.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis
A clinical study is evaluating immune response status in patients with visceral leishmaniasis before and after treatment; the trial is curre…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
A completed study reports the incidence of relapse and Post-kala-azar dermal leishmaniasis in South Sudan among visceral leishmaniasis patie…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Mediterranean Visceral Leishmaniasis With Leishmania Infantum
Clinical trial update for Mediterranean visceral leishmaniasis caused by Leishmania infantum; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
A proof-of-concept and validation study of a Leishmania antigen rapid diagnostic test for visceral leishmaniasis has been terminated.
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)
A recruiting clinical trial in Emilia-Romagna (Leishmania-2019) is investigating visceral leishmaniasis.
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa [Phase 3]
Phase III trial update for miltefosine/paromomycin in treating visceral leishmaniasis in Eastern Africa has completed.
-
FDA approval · 2022-03-17FDA Approved: PENTAMIDINE ISETHIONATE — Original Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved the original application for Pentamidine isethionate (generic) from XGen Pharmaceuticals DJB, Inc., authorizing its U.S. market…
-
FDA approval · 2021-05-25FDA Approved: IMPAVIDO — Supplemental Application (Profounda, Inc.)
The FDA approved a supplemental application for IMPAVIDO (miltefosine) filed by Profounda, Inc.
-
FDA approval · 2019-04-24FDA Approved: PENTAMIDINE ISETHIONATE — Original Application (Seton Pharmaceuticals)
FDA approved pentamidine isethionate in an Original Application by Seton Pharmaceuticals. It is indicated for Pneumocystis jirovecii pneumon…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. [Phase 3]
Phase 3 clinical trial update evaluating Ambisome alone and in combination with Miltefosine for treatment of visceral leishmaniasis in HIV-p…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study [Phase 3]
Completed Phase 3 cohort study evaluating pentamidine prophylaxis to prevent relapses of visceral leishmaniasis in HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh [NA]
This document reports the completion of a pilot capacity-building study for a multi-centre randomized trial evaluating treatment for viscera…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. [Phase 2]
Phase 2 clinical trial comparing sitamaquine to amphotericin B for visceral leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil [Phase 4]
A Phase 4 clinical trial evaluating efficacy and safety of drugs for visceral leishmaniasis in Brazil was terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children [Phase 4]
Phase 4 trial evaluating amphotericin B for visceral leishmaniasis in Brazilian children has been completed.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) [Phase 3]
Phase 3 trial evaluating replacement insecticide strategies to control visceral leishmaniasis. The study status is completed.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Immunogenetics of Visceral Leishmaniasis
An NHGRI-sponsored study investigating the immunogenetics of visceral leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa [Phase 2]
A Phase 2 trial update evaluating safety and efficacy of three regimens—Sodium Stibogluconate with AmBisome, Miltefosine with AmBisome, and …
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) [NA]
A completed study (NIDIAG-Fever) evaluated rapid diagnostic tests and clinical/laboratory predictors to diagnose tropical diseases in patien…